More than 600 lung transplants have been performed since Northwestern Medicine launched its lung transplant program back in ...

More lungs were offered for transplantation from DCD donors than expected from historical organ yields, whether with ...

Getinge’s decision to leave the surgical perfusion market will benefit LivaNova, an already dominant player in the sector that is set to capture market share, according to GlobalData experts.

TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as ...

“In 2024, we used ‘lungs in a box,’ also known as lung perfusion, to repair the most number of donor lungs that were not initially usable,” said Chief of Thoracic Surgery Dr. Ankit Bharat.

Cigarette smoking is by far the biggest risk factor for lung cancer, data shows — but in a surprising turn of events, the most common form of the disease is primarily found in non-smokers.

Getinge plans to phase out its surgical perfusion business in a move expected to benefit major players such as LivaNova, ...